β¨ Medicines Classification
NEW ZEALAND GAZETTE, No. 65 β 11 JUNE 2015
Ipamorelin
Ipilimumab
Isoconazole; except in medicines for vaginal or dermal use
Ivacaftor
Ledipasvir
Linagliptin
Lixisenatide
Loteprednol
Loteprednol etabonate
Lovastatin; except when present as an unmodified, naturally occurring substance in a food that has not been subject to a manufacturing process other than heating, freezing, drying, preserving, bottling, canning, or packaging in retort pouches
Lurasidone
Macitentan
Melanocyte stimulating compounds
Meningococcal vaccine; except when administered to a person 16 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health
Mercurochrome; except when specified elsewhere in this notice
Micafungin
Miconazole; except when specified elsewhere in this notice; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Mirabegron
Nalmefene
Nintedanib
Nitisinone
Nitrous Oxide; when supplied for inhalation
Nomegestrol
Nystatin; except when specified elsewhere in this notice; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board
Obinutuzumab
Ocriplasmin
Ofatumumab
Olodaterol
Ombitasvir
Omeprazole; except when specified elsewhere in this notice
Oseltamivir; except when specified elsewhere in this notice
Pantoprazole; except when specified elsewhere in this notice
Pasireotide
Pasireotide diaspartate
Perampanel
Pertuzumab
Pitavastatin
Plerixafor
Pomalidomide
Pradofloxacin
Pralatrexate
Prucalopride
Next Page →
β¨ LLM interpretation of page content
π₯
Classification of Medicines
(continued from previous page)
π₯ Health & Social WelfareMedicines, Classification, Prescription, Restricted, Pharmacy-only
NZ Gazette 2015, No 65